1. LICENSING PRESENTATION September 2013
Tristram Lake
Head of Licensing and Sales
Neogen N.V.

2. CONTENTS The aim of this presentation is to communicate to you...
Our mission
Our vision
Who we are
What we do
How we do it

3. Who are we? Developments International Alter Pharma N.V. Neogen Dev.
Interntational SP
NSP
GSP
Steac
Developments
International

4. our Basic idea
We cover niche, overlooked and local markets with focus on older molecules, along with alternative forms and strengths when possible
Neogen
Generic Companies wishing to extend their Portfolio
No skills or willingness to undertake developments
Inlicensing of products

5. Roadmap 2 – 4 years Core competences Market intel
Product selection
Finished dose development
Dossier compilation
Submission & registration
Supply & support
API development
Sales & marketing
Core competences
Market intel
Qualification & management of 3rd party CMO’s
Patent search
Commercial scale production
Formulation
Stability testing
Risk assessment
Regulatory strategy
Lab scale batches

6. Dosage FORMs Injectables: In-house development. EU CMOs Oral forms:
3rd party development or dossier update
manufacturing outsourced in Europe and Asia
BE performed if necessary
Other forms: creams, sprays
Developed and manufactured in EU based CMOs
Supported by clinical study if necessary

7. SELECTION PRODUCT Opportunity driven
Focus on niche products (turnover < EUR 20 million or available only in limited number of countries).
25 projects completed or in final development stages
Approx. 60 other projects in pipeline
Several products already launched

8. WIN Business Model License and long term supply agreement Dossier fee
Supply price model adapted to product and territory
Registration support
Supply chain management
Ex-works

9. COMPANY FIGURES
Team of circa 30 people located in Belgium, Denmark, France, Hungary, Ireland, Netherlands
2012 turnover EUR 14 mio.
5 products launched in 30 countries
License and Supply deals signed for ANZAC, Canada, China, Europe, LATAM, MENA, RSA, Russia/CIS, SAE, US
> 120 License and Supply deals signed
> 70 clients
Distribution deals done in non-regluated markets

10. OUR STRENGTHS
Multicultural team, allowing local focus with global perspective
Strong expertise in:
product selection
dossier development
licensing-out
supply of product to the pharma industry
Dynamic, fast and pragmatic decision process

11. Advantages of partnering with Us
Full Regulatory Support: before, during and after granting MA
Supply Chain Management
Continuos Competitive Sourcing: API + Manufacturer
Sourcing Strategy: 2 APIs sources + 2 Manufacturers (Asia, EU)
Flexibility and speed
Outsourcing advantages
Fast moving, dynamic company with global experience

12. CONTACT Tristram Lake Head of Licensing NEOGEN N.V.
Square Marie Curie 50 – 1070 Anderlecht – Belgium -